Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05468970

Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors

It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Bone and Soft Tissue Tumors Clinical Features Neoplasms Neoplasms by Site Soft Tissue Neoplasms

Age range

6 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Bone and Soft Tissue ,Henan Cancer Hospital

Zhengzhou, Henan, 450008, China

Location status: Recruiting

Location contact

Zhichao Tian, Dr.

CONTACT

[email protected]

+8618737187831

About this study

It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor. This study is a single-center, prospective, real-world observational study that plans to enroll all eligible patients. Basic information, treatment methods, and prognostic information of these patients were collected.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All ages, male and female.

The pathological diagnosis of BSTS in our hospital was a subtype.

Has received at least one hospitalization in this hospital.

The target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes.

Exclusion criteria

No definite pathology.

Treatment and study plan

No intervention

Other

NO Intervention

Primary outcomes

  1. Overall survival

    Time frame: Up to approximately 120months

    Pathologically confirmed events leading to death

  2. 6/5000 Progression-free survival

    Time frame: Up to approximately 48months

    The time from the first use of the treatment to the observation of disease progression

Study contacts

Contact information is provided by the study sponsor or research team.

Wang Jiaqiang, Dr.

CONTACT

[email protected]

13592413731

Sponsors and collaborators

Lead sponsor

Henan Cancer Hospital

Other Gov

Registry information

Official study title

Single-center Real World Prospective Observational Study of Clinical Features, Treatment Patterns, and Survival of Bone and Soft Tissue Tumors

Important dates

Study start
2022
Primary completion
2032
Study completion
2032
First posted
Jul 21, 2022
Registry last updated
Sep 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.